Immuron (IMRNW) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $0.07 to $0.11
• 50-Day Range: $0.07 to $0.07
• 52-Week Range: $0.02 to $1.20
• Volume: 96,555 shs
• Average Volume: 39,155 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IMRNW Stock Analysis - Frequently Asked Questions

When did Immuron IPO?

Immuron (IMRNW) raised $6,000 in an IPO on Friday, June 9th 2017. The company issued 600,000 shares at $0.01 per share. Joseph Gunnar and Rodman & Renshaw (a unit of H.C. Wainwright & Co.) served as the underwriters for the IPO and WallachBeth Capital, LLC was co-manager.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Pharmaceutical Preparation Manufacturing
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IMRNW
• CIK: 1660046
• Web: www.immuron.com.au
• Phone: 61398245254
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A